HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm

被引：0
|
作者：
T Van Gorp
I Cadron
E Despierre
A Daemen
K Leunen
F Amant
D Timmerman
B De Moor
I Vergote
机构：
[1] Universitaire Ziekenhuizen Leuven,Division of Gynaecological Oncology, Department of Obstetrics and Gynaecology
[2] Katholieke Universiteit Leuven,Division of Gynaecological Oncology, Department of Obstetrics and Gynaecology
[3] Herestraat 49,Department of Electrical Engineering
[4] MUMC+,undefined
[5] GROW – School for Oncology and Developmental Biology,undefined
[6] ESAT-SCD/SISTA,undefined
[7] Katholieke Universiteit Leuven,undefined
[8] Kasteelpark Arenberg 10,undefined
来源：
British Journal of Cancer | 2011年 / 104卷
关键词：
HE4; CA125; ovarian cancer; Risk of Ovarian Malignancy Algorithm;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：863 / 870
页数：7
相关论文
共 50 条
  • [1] HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm
    Van Gorp, T.
    Cadron, I.
    Despierre, E.
    Daemen, A.
    Leunen, K.
    Amant, F.
    Timmerman, D.
    De Moor, B.
    Vergote, I.
    BRITISH JOURNAL OF CANCER, 2011, 104 (05) : 863 - 870
  • [2] Diagnostic Value of HE4, CA125 and Risk of Ovarian Malignancy Algorithm in Detecting Ovarian Cancer
    Jafari-Shobeiri, Mehri
    Parizad, Marzye
    Nazari, Fatemeh
    Ouladsahebmadarek, Elaheh
    Sayyah-Melli, Manizheh
    Mostafa-Gharabaghi, Parvin
    Esmaili, Heidarali
    Parizad, Mohammad Amin
    Pouraliakbar, Yasmin
    Sepasi, Farnaz
    INTERNATIONAL JOURNAL OF WOMENS HEALTH AND REPRODUCTION SCIENCES, 2015, 3 (04): : 208 - 211
  • [3] Diagnostic performance of CA 125, HE4, and risk of Ovarian Malignancy Algorithm for ovarian cancer
    Kim, Boyeon
    Park, Yongjung
    Kim, Banseok
    Ahn, Hyo Jun
    Lee, Kyung-A
    Chung, Jae Eun
    Han, Sang Won
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2019, 33 (01)
  • [4] HE4 and CA125 in ovarian malignancy
    Perovic, M.
    CLINICA CHIMICA ACTA, 2022, 530 : S62 - S62
  • [5] COMPARISON OF HE4, CA125, AND RISK OF OVARIAN MALIGNANCY ALGORITHM IN THE PREDICTION OF OVARIAN CANCER IN KOREAN WOMEN
    Cho, H. Y.
    Sung-ho, P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1463 - 1463
  • [6] Comparison of HE4, CA125, and Risk of Ovarian Malignancy Algorithm in the Prediction of Ovarian Cancer in Korean Women
    Cho, Hye Yon
    Park, Sung Ho
    Park, Young Han
    Kim, Hong Bae
    Kang, Jung Bae
    Hong, Seung Hwa
    Kyung, Min Sun
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2015, 30 (12) : 1777 - 1783
  • [7] Diagnostic Performance of Risk of Ovarian Malignancy Algorithm Against CA125 and HE4 in Connection With Ovarian Cancer A Meta-analysis
    Dayyani, Farshid
    Uhlig, Steffen
    Colson, Bertrand
    Simon, Kirsten
    Rolny, Vinzent
    Morgenstern, David
    Schlumbrecht, Matthew
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2016, 26 (09) : 1586 - 1593
  • [8] COMPARISON OF HE4, CA125, AND RISK OF OVARIAN MALIGNANCY ALGORITHM (ROMA) IN THE PREDICTION OF OVARIAN CANCER IN KOREAN WOMEN
    不详
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 991 - 991
  • [9] HE4, CA125 AND RISK OF OVARIAN MALIGNANCY ALGORITHM (ROMA) AS DIAGNOSTIC TOOLS OF OVARIAN CANCER IN PATIENTS WITH PELVIC MASS: AN ITALIAN MULTICENTER PROSPECTIVE STUDY
    Romagnolo, C.
    Leon, A. E.
    Fabricio, A. S. C.
    Del Pup, L.
    Papadakis, C.
    Odicino, F. E.
    Ravaggi, A.
    Zanotti, L.
    Bandiera, E.
    Squarcina, E.
    Scattolo, N.
    Steffan, A.
    Polesel, J.
    Taborelli, M.
    Cervo, S.
    Maggino, T.
    Gion, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 528 - 529
  • [10] Cancer Antigen 125 (CA125), Human Epididymis Protein 4 (HE4), Risk of Malignancy Index (RMI), and Risk of Ovarian Malignancy Algorithm (ROMA) as Diagnostic Tests in Ovarian Cancer
    Bouzari, Zinatossadat
    Rahimi, Hadiseh
    Gholinia, Hemmat
    Yazdani, Shahla
    Hajian-Tilaki, Karimollah
    Soleimani, Mohammad Jafar
    INTERNATIONAL JOURNAL OF CANCER MANAGEMENT, 2019, 12 (01)
12345